Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Kyowa Hakko Kirin has submitted an additional indication application to Japan's Review Committee for the changes made in the maximum dosages of its synthesized penicillin - Pasetocin Capsules 125, Pasetocin Capsules 250, Pasetocin Fine Granules 10% and Pasetocin Tablets 250 to treat pediatric infectious diseases.
Subscribe to our email newsletter
The changes were made based on a request from Ministry of Health, Labor and Welfare for development of new dosages of Pasetocin.
Pasetocin is a broad spectrum antibiotic that, when administered in higher doses, promises to be effective against various bacterial strains.
The company claims as such, having also considered factors such as the approval status of the medicine overseas, we have filed application regarding a change in the maximum daily applied dose with respect to indicated strains and indications that have already been approved.